Plum SEC
  • Korean Market
  • Privacy Policy

Korean Market

  • Reset (View All)

  • ★★★★★
  • ★★★★
  • ★★★
  • ★★
  • ★

  • ★

  • ★
  • ★★
  • ★★★
  • ★★★★
  • ★★★★★
All Disclosures
OTHR
HLB PHARMACEUTICAL
★★

Outside Director Resignation Causes Failure to Meet Legal Board Composition Requirement

  05/22/2026, 04:01 PM
ISSU
HLB PHARMACEUTICAL
★★

HLB Pharma Announces 120 Billion Won Rights Offering - Dilution and Financial Risks Highlighted

  05/13/2026, 05:35 PM
MATR
HLB PHARMACEUTICAL
★★

HLB Pharma Announces 32.8% Rights Offering with Undisclosed Use of Proceeds

  05/13/2026, 04:57 PM
PERI
HLB PHARMACEUTICAL
★★

HLB Pharmaceutical 2026 Q1: Revenue up 89% YoY, operating profit nearly equals full year 2025

  05/13/2026, 04:05 PM
한국어 | English | 中文 | 日本語
Plum SEC © 2026.05.25
The information provided on this site is for reference only and we do not guarantee its accuracy or completeness. Users are solely responsible for any investment decisions made based on this information.